Wells Fargo Keeps Their Hold Rating on E. W. Scripps Company Class A (SSP)
Wells Fargo analyst Steven Cahall maintained a Hold rating on E. W. Scripps Company Class A (SSP – Research Report) on May 9 and set a price target of $2.80. The company's shares closed last Friday at $2.32.
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Cahall covers the Communication Services sector, focusing on stocks such as Paramount Global Class B, Roku, and E. W. Scripps Company Class A. According to TipRanks, Cahall has an average return of 6.1% and a 52.35% success rate on recommended stocks.
E. W. Scripps Company Class A has an analyst consensus of Moderate Buy, with a price target consensus of $6.93.
Based on E. W. Scripps Company Class A's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $728.38 million and a net profit of $95.39 million. In comparison, last year the company earned a revenue of $615.77 million and had a GAAP net loss of $255.76 million
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
5 minutes ago
- Business Insider
Amaze files to sell 44.62M shares of common stock for holders
16:50 EDT Amaze (AMZE) files to sell 44.62M shares of common stock for holders Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Business Insider
37 minutes ago
- Business Insider
DocMorris (DOCM) Receives a Hold from ZKB
DocMorris (DOCM – Research Report) received a Hold rating and price target from ZKB analyst today. The company's shares closed today at CHF7.61. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Currently, the analyst consensus on DocMorris is a Moderate Buy with an average price target of CHF18.20. Based on DocMorris' latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of CHF520.76 million and a GAAP net loss of CHF59.32 million. In comparison, last year the company earned a revenue of CHF506.51 million and had a GAAP net loss of CHF59.33 million
Business Insider
37 minutes ago
- Business Insider
Tivic Health files to sell 8.44M shares of common stock for holders
16:36 EDT Tivic Health (TIVC) files to sell 8.44M shares of common stock for holders Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
